Growing community of inventors

Fullerton, CA, United States of America

Gary J Beck

Average Co-Inventor Count = 3.81

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 127

Gary J BeckChin-Ming Chang (11 patents)Gary J BeckAmy L Batoosingh (11 patents)Gary J BeckCynthia C Pratt (11 patents)Gary J BeckOrest Olejnik (2 patents)Gary J BeckEdward D S Kerslake (2 patents)Gary J BeckGary J Beck (13 patents)Chin-Ming ChangChin-Ming Chang (34 patents)Amy L BatoosinghAmy L Batoosingh (11 patents)Cynthia C PrattCynthia C Pratt (11 patents)Orest OlejnikOrest Olejnik (58 patents)Edward D S KerslakeEdward D S Kerslake (6 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Allergan, Inc. (7 from 2,285 patents)

2. Allergan Sales, Inc. (6 from 228 patents)


13 patents:

1. 9907801 - Combination of brimonidine and timolol for topical ophthalmic use

2. 9907802 - Combination of brimonidine and timolol for topical ophthalmic use

3. 9770453 - Combination of brimonidine and timolol for topical ophthalmic use

4. 9474751 - Combination of brimonidine and timolol for topical ophthalmic use

5. 8748425 - Combination of brimonidine and timolol for topical ophthalmic use

6. 8354409 - Combination of brimonidine and timolol for topical ophthalmic use

7. 8133890 - Combination of brimonidine and timolol for topical ophthalmic use

8. 7642258 - Combination of brimonidine and timolol for topical ophthalmic use

9. 7323463 - Combination of brimonidine and timolol for topical ophthalmic use

10. 7320976 - Combination of brimonidine and timolol for topical ophthalmic use

11. 7030149 - Combination of brimonidine timolol for topical ophthalmic use

12. 6723353 - Preserved cyclodextrin-containing compositions

13. 6358935 - Preserved cyclodextrin-containing compositions

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…